Key result
Chinese herbal monomers attenuate preclinical diabetic cardiomyopathy through Nrf2 upregulation and pathway crosstalk.
Why the study?
Diabetic cardiomyopathy is a major cause of poor prognosis and survival in diabetes, and Chinese herbal monomers may attenuate it via Nrf2 signaling pathway crosstalk.
Do Chinese herbal monomers ameliorate diabetic cardiomyopathy via Nrf2 signaling and its crosstalk with other pathways?
Do Chinese herbal monomers ameliorate diabetic cardiomyopathy via Nrf2 signaling and its crosstalk with other pathways?
This narrative review highlights the potential of Chinese herbal monomers as therapeutic candidates for diabetic cardiomyopathy by targeting Nrf2 signaling and its crosstalk with inflammatory, metabolic, and fibrotic pathways.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for Chinese herbal monomers in diabetic cardiomyopathy; should not change practice without clinical trials.
Diabetic cardiomyopathy (DCM) is the main factor responsible for poor prognosis and survival in patients with diabetes. The highly complex pathogenesis of DCM involves multiple signaling pathways, including nuclear factor‐ κ B (NF‐ κ B) signaling pathway, adenosine monophosphate‐activated protein kinase (AMPK) signaling pathway, phosphatidylinositol 3‐kinase‐protein kinase B (Akt) signaling pathway, mitogen‐activated protein kinase (MAPK) signaling pathway, and transforming growth factor‐ β (TGF‐ β ) signaling pathway. Nuclear factor erythroid‐2‐related factor 2 (Nrf2) seems essential to the amelioration of the progression of DCM, not only through counterbalancing oxidative stress, but also through interacting with other signaling pathways to combat inflammation, the disorder in energy homeostasis and insulin signaling, and fibrosis. It has been evidenced that Chinese herbal monomers could attenuate DCM through the crosstalk of Nrf2 with other signaling pathways. This article has summarized the pathogenesis of DCM (especially in oxidative stress), the beneficial effects of ameliorating DCM via the Nrf2 signaling pathway and its crosstalk, and examples of Chinese herbal monomers. It will facilitate pharmacological research and development to promote the utilization of traditional Chinese medicine in DCM.
No takes yet. Share an insight, caveat, or question.
Gao et al. (2022) conducted a review in Diabetic cardiomyopathy. Chinese herbal monomers was evaluated on Amelioration of diabetic cardiomyopathy via Nrf2 signaling and pathway crosstalk. Chinese herbal monomers attenuate diabetic cardiomyopathy in preclinical models by upregulating Nrf2 and modulating crosstalk with NF-κB, AMPK, Akt, MAPK, and TGF-β pathways.
Synapse has enriched 10 related papers. Consider them for comparative context: